Hikma Pharmaceuticals (HIK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,939.00p
   
  • Change Today:
    -25.00p
  • 52 Week High: 2,340.00p
  • 52 Week Low: 1,772.00p
  • Currency: UK Pounds
  • Shares Issued: 221.89m
  • Volume: 1,793,541
  • Market Cap: £4,302.38m
  • RiskGrade: 125
  • Beta: 0.02

HIK Overview

Hikma is an international pharmaceutical company conducting operations through three businesses: generic pharmaceuticals, branded pharmaceuticals and injectable pharmaceuticals. The company sells 113 branded and non-branded generic pharmaceutical products in 34 countries worldwide. The majority of Hikma’s operations are in the United States, the Middle East and North Africa Region and Europe.

Key Personnel

CEO: Riad Mishlawi
Executive Chairman: Said Darwazah
Executive Vice Chairman: Mazen Darwazah
Independent Non-Executive Director: Laura Balan Balan
Independent Non-Executive Director: Mary (Nina) Henderson
Independent Non-Executive Director: Cynthia Schwalm
Independent Non-Executive Director: Deneen Vojta
Independent Non-Executive Director: Douglas Hurt
Senior Independent Director: Victoria Hull
Non-Executive Dir: Ali Al-Husry

Contact Details

Address: 1 New Burlington Place, London,United Kingdom, W1S 2HR
Phone: +44 (0)20 7399 2760
Fax: +44 (0)20 7399 2761
Website: http://www.hikma.com

Listings

Sector: Pharma and Biotech(LSE)
Index: FTSE 100, FTSE 350, FTSE All-Share
Overseas Listings: BATSLON:HIKL
ISIN: GB00B0LCW083

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

HIK Market Data

Currency UK Pounds
Share Price 1,939.00p
Change Today -25.00p
% Change -1.27 %
52 Week High 2,340.00p
52 Week Low 1,772.00p
Volume 1,793,541
Shares Issued 221.89m
Market Cap £4,302.38m
Beta 0.02
RiskGrade 125

HIK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
85.2% below the market average85.2% below the market average85.2% below the market average85.2% below the market average85.2% below the market average
11.63% above the sector average11.63% above the sector average11.63% above the sector average11.63% above the sector average11.63% above the sector average
Price Trend
34.7% below the market average34.7% below the market average34.7% below the market average34.7% below the market average34.7% below the market average
51.11% above the sector average51.11% above the sector average51.11% above the sector average51.11% above the sector average51.11% above the sector average
Income
19.17% above the market average19.17% above the market average19.17% above the market average19.17% above the market average19.17% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
41.42% above the market average41.42% above the market average41.42% above the market average41.42% above the market average41.42% above the market average
6.67% above the sector average6.67% above the sector average6.67% above the sector average6.67% above the sector average6.67% above the sector average

What The Brokers Say

Strong Buy 6
Buy 3
Neutral 3
Sell 0
Strong Sell 0
Total 12
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

HIK Dividends

  Latest Previous
  Final Interim
Ex-Div 20-Mar-25 15-Aug-24
Paid 01-May-25 20-Sep-24
Amount 48.00¢ 32.00¢

Trades for 01-Aug-2025

Time Volume / Share Price
14:51 0 @ 1,935.00p
11:10 704,109 @ 1,936.00p
11:10 704,109 @ 1,936.00p
16:47 6,199 @ 1,934.03p
16:35 2,045 @ 1,939.00p

HIK Key Personnel

CEO Riad Mishlawi

Top of Page